Sodium Oxybate for Narcolepsy: Explaining Untoward Effects and Recommending New Approaches in Light of Prevailing Receptor Pharmacology.

VanWert, Adam L; McCune, Dan F; Brown, Kaitlyn M; Bommareddy, Ajay; Manning, Dana H; Roman, Crystal L

VanWert, Adam L; McCune, Dan F; Brown, Kaitlyn M; Bommareddy, Ajay; Manning, Dana H; Roman, Crystal L.

Afiliación

VanWert AL; Nesbitt School of Pharmacy at Wilkes University, Wilkes-Barre, PA, USA.
McCune DF; Nesbitt School of Pharmacy at Wilkes University, Wilkes-Barre, PA, USA.
Brown KM; Nesbitt School of Pharmacy at Wilkes University, Wilkes-Barre, PA, USA.
Bommareddy A; Nesbitt School of Pharmacy at Wilkes University, Wilkes-Barre, PA, USA.
Manning DH; Nesbitt School of Pharmacy at Wilkes University, Wilkes-Barre, PA, USA.
Roman CL; St Luke's University Hospital, Bethlehem, PA, USA.

J Pharm Technol ; 30(6): 240-243, 2014 Dec.

Article en En | MEDLINE | ID: mdl-34860897

Palabras clave

GHB; Xyrem; gamma-hydroxybutyrate; naloxone; narcolepsy; oxybate; toxicology

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pharm Technol Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google